Plus Therapeutics News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Plus Therapeutics Inc PSTV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.02 -0.88% 2.24 19:46:24
Open Price Low Price High Price Close Price Prev Close
2.26 2.13 2.35 2.17 2.26
more quote information »

Recent News

Date Time Source Heading
5/04/202108:09SEEKPlus Therapeutics shares rise 5% on Rhenium NanoLiposome..
5/04/202107:30GLOBEPlus Therapeutics Announces Key RNL™ Development and cGMP..
4/22/202116:15SEEKPlus Therapeutics EPS beats by $0.03
4/22/202116:11EDGARCurrent Report Filing (8-k)
4/22/202116:06EDGARQuarterly Report (10-q)
4/22/202116:05GLOBEPlus Therapeutics Reports First Quarter 2021 Financial..
4/08/202107:30GLOBEPlus Therapeutics to Announce First Quarter 2021 Financial..
4/05/202117:07EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
3/24/202112:15SEEKPlus Therapeutics and Piramal Pharma ink master services..
3/23/202107:41SEEKPlus Therapeutics (PSTV) shares surge 48% on Rhenium..
3/23/202107:30GLOBEPlus Therapeutics Enters Into Master Services Agreement with..
3/18/202107:30GLOBEPlus Therapeutics to Participate in Upcoming Virtual..
3/12/202116:15EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
3/03/202107:30GLOBEPlus Therapeutics to Participate in Upcoming Virtual..
2/26/202116:29EDGARSecurities Registration Statement (s-1)
2/26/202112:41EDGARAmended Statement of Ownership (sc 13g/a)
2/26/202110:11EDGARAmended Statement of Ownership (sc 13g/a)
2/23/202116:28EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/23/202116:07EDGARCurrent Report Filing (8-k)
2/22/202116:19EDGARAnnual Report (10-k)
2/22/202116:13SEEKPlus Therapeutics EPS misses by $1.46
2/22/202116:05GLOBEPlus Therapeutics Reports Fourth Quarter and Full Year 2020..
2/18/202116:06EDGARStatement of Changes in Beneficial Ownership (4)
2/18/202116:06EDGARStatement of Changes in Beneficial Ownership (4)
2/11/202116:15GLOBEPlus Therapeutics to Announce Fourth Quarter and Full Year..
2/11/202107:30GLOBEPlus Therapeutics to Participate in BIO CEO & Investor..
2/10/202115:23EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202112:20SEEKPlus Therapeutics keeps soaring after trading halt
1/29/202106:55EDGARAmended Statement of Ownership (sc 13g/a)
1/05/202116:15GLOBEPlus Therapeutics to Participate in Upcoming January..
12/15/202007:30GLOBEPlus Therapeutics Completes Sixth Dosing Cohort in ReSPECT™..
12/08/202007:30GLOBEPlus Therapeutics to Present at 13th Annual LD Micro Main..
12/02/202007:01EDGARStatement of Changes in Beneficial Ownership (4)
12/01/202007:30GLOBEPlus Therapeutics Expands ReSPECT™ Clinical Trial to MD..
11/19/202008:00GLOBEPlus Therapeutics Announces Positive Interim Data from..
11/16/202008:00GLOBEPlus Therapeutics to Participate in Upcoming November..
11/13/202007:30GLOBEPlus Therapeutics Announces Webinar to Present ReSPECT™..
11/06/202016:47EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
11/06/202006:10EDGARNotice of Effectiveness (effect)
11/05/202007:00GLOBEPlus Therapeutics Announces Formation of Scientific Advisory..
10/29/202016:27EDGARSecurities Registration Statement (s-1)
10/29/202007:00GLOBEPlus Therapeutics Announces Initiation of Final Cohort of..
10/23/202016:15EDGARCurrent Report Filing (8-k)
10/22/202016:17EDGARCurrent Report Filing (8-k)
10/22/202016:06EDGARQuarterly Report (10-q)
10/22/202016:05GLOBEPlus Therapeutics Reports Third Quarter 2020 Financial..
10/20/202006:05EDGARNotice of Effectiveness (effect)
10/15/202007:00GLOBEPlus Therapeutics to Present at the Cancer Innovation Summit
10/14/202016:15GLOBEPlus Therapeutics to Announce Third Quarter 2020 Financial..
10/09/202016:10EDGARSecurities Registration Statement (simplified Form) (s-3)
See more news about this stock »

Your Recent History
Plus Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.